[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100632626":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":24,"locations":34,"responsibleParty":158,"collaborators":160,"id":166,"slug":167,"hasResults":168,"nctId":169,"briefTitle":170,"officialTitle":171,"acronym":11,"eligibilityCriteria":172,"healthyVolunteers":168,"sex":173,"minAge":174,"maxAge":11,"enrollmentInfo":175,"targetDuration":11,"studyType":178,"phases":179,"briefSummary":181,"conditions":182,"keywords":184,"overallStatus":37,"whyStopped":11,"lastUpdateSubmitDate":187,"lastUpdatePostDateStruct":188,"startDateStruct":191,"completionDateStruct":193,"leadSponsor":195,"locationsCount":196},{"fullName":5,"class":6},"Ocular Therapeutix, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"OTX-TKI","EXPERIMENTAL",null,[13],"Drug: OTX-TKI",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":11},"DRUG","Intravitreal Injection of OTX-TKI",[9],[20],{"name":21,"affiliation":22,"role":23},"Dilsher Dhoot, MD","California Retina Consultants (CRC)-Bakersfield","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":11,"email":29},"Clinical Project Manager","CONTACT","781-357-4000","clinicalaffairs@ocutx.com",{"name":31,"role":27,"phone":32,"phoneExt":11,"email":33},"Nichole Wilkes","770-375-1020","nwilkes@ocutx.com",[35,55,66,83,99,116,127,143],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"California Retina Consultants (CRC)","RECRUITING","Bakersfield","California","93309","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-119.01871,35.37329,{"lat":47,"lon":46},[50,54],{"name":51,"role":27,"phone":52,"phoneExt":11,"email":53},"Luis Lopez","661-524-0162","luis.lopez@californiaretina.com",{"name":21,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":36,"status":37,"city":56,"state":39,"zip":57,"country":41,"countryCode":42,"cosmosGeoPoint":58,"geoPoint":62,"contacts":63},"Santa Barbara","93103",{"type":44,"coordinates":59},[60,61],-119.69819,34.42083,{"lat":61,"lon":60},[64],{"name":21,"role":27,"phone":28,"phoneExt":11,"email":65},"ddhoot@yahoo.com",{"facility":67,"status":37,"city":68,"state":69,"zip":70,"country":41,"countryCode":42,"cosmosGeoPoint":71,"geoPoint":75,"contacts":76},"Retina Group of New England","Waterford","Connecticut","06385",{"type":44,"coordinates":72},[73,74],-72.13597,41.3417,{"lat":74,"lon":73},[77,81],{"name":78,"role":27,"phone":79,"phoneExt":11,"email":80},"Ashley Parent","860-444-1292","aparent@retinagroupofnewengland.com",{"name":82,"role":23,"phone":11,"phoneExt":11,"email":11},"Nauman A Chaudhry, MD",{"facility":84,"status":37,"city":85,"state":86,"zip":87,"country":41,"countryCode":42,"cosmosGeoPoint":88,"geoPoint":92,"contacts":93},"Retina Group of Florida - Fort Lauderdale","Fort Lauderdale","Florida","33308",{"type":44,"coordinates":89},[90,91],-80.14338,26.12231,{"lat":91,"lon":90},[94,98],{"name":95,"role":27,"phone":96,"phoneExt":11,"email":97},"Eduardo Uchiyama, MD","954-776-6800","euchiyama@rgfla.com",{"name":95,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":100,"status":37,"city":101,"state":102,"zip":103,"country":41,"countryCode":42,"cosmosGeoPoint":104,"geoPoint":108,"contacts":109},"Cumberland Valley Retina Associates","Hagerstown","Maryland","21740",{"type":44,"coordinates":105},[106,107],-77.71999,39.64176,{"lat":107,"lon":106},[110,114],{"name":111,"role":27,"phone":112,"phoneExt":11,"email":113},"Brittany Carson","301-665-1712","BrittanyC@retinacare.net",{"name":115,"role":23,"phone":11,"phoneExt":11,"email":11},"Allen Hu, MD",{"facility":117,"status":37,"city":101,"state":102,"zip":103,"country":41,"countryCode":42,"cosmosGeoPoint":118,"geoPoint":120,"contacts":121},"Mid Atlantic Retina Specialists",{"type":44,"coordinates":119},[106,107],{"lat":107,"lon":106},[122,126],{"name":123,"role":27,"phone":124,"phoneExt":11,"email":125},"Adam Gerstenblith, MD","240-313-9500","adamgerstenblith@gmail.com",{"name":123,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":128,"status":37,"city":129,"state":130,"zip":131,"country":41,"countryCode":42,"cosmosGeoPoint":132,"geoPoint":136,"contacts":137},"Palmetto Retina Center","West Columbia","South Carolina","29619",{"type":44,"coordinates":133},[134,135],-81.07398,33.99349,{"lat":135,"lon":134},[138,142],{"name":139,"role":27,"phone":140,"phoneExt":11,"email":141},"Nitin Nigam, MD","803-867-7059","nnigam@palmettoretina.com",{"name":139,"role":23,"phone":11,"phoneExt":11,"email":11},{"facility":144,"status":37,"city":145,"state":146,"zip":147,"country":41,"countryCode":42,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"Austin Retina Associates","Austin","Texas","78705",{"type":44,"coordinates":149},[150,151],-97.74306,30.26715,{"lat":151,"lon":150},[154,157],{"name":155,"role":27,"phone":156,"phoneExt":11,"email":11},"Robert William Wong, MD","512-451-0103",{"name":155,"role":23,"phone":11,"phoneExt":11,"email":11},{"type":159,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR",[161,163],{"name":162,"class":6},"Fortrea",{"name":164,"class":165},"Duke Reading Center","UNKNOWN","100632626","phase-3-study-to-evaluate-long-term-safety-of-intravitreal-otx-tki-axitinib-implant-in-participants-with-neovascular-age-related-macular-degeneration-who-successfully-completed-2-year-otx-tki-2023-amd-301-or-otx-tki-2023-amd-303-study-100632626",false,"NCT07516132","Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study","A Phase 3b, Multicenter, Open-Label, Extension Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study","Inclusion Criteria:\n\n* Participants with a diagnosis of nAMD in the study eye who successfully completed Study OTX-TKI-2023-AMD-301 through Week 104 or Study OTX-TKI-2023-AMD-303 through Week 96\n* Have adequate ocular media and adequate pupillary dilation in the study eye to permit good quality fundus imaging\n* Are able and willing to comply with all study requirements and visits\n* Have provided written informed consent\n\nExclusion Criteria:\n\n* Have significant intraocular or periocular infection (bacterial, viral, or fungal) in the study eye within 3 months prior to Day 1\n* History of intraocular inflammation in the study eye\n* Have evidence of a rhegmatogenous retinal detachment or visually significant\u002Fsevere epiretinal membrane, macular hole, tear of the retinal pigment epithelium in the macula, or other macular\n* Presence of an intercurrent illness or condition that in the opinion of the Investigator, may place the participant at an unacceptable risk, preventing the participant from completing the study or confound the interpretation of study results\n* Female participants who are pregnant (had a positive urine test at the Baseline visit \\[Day 1\\]) or breastfeeding or intend to become pregnant during the study, who are unwilling to use 2 forms of highly effective contraception from baseline until they exit the study or at least 3 months after the last study treatment, whichever is later.","ALL","50 Years",{"count":176,"type":177},850,"ESTIMATED","INTERVENTIONAL",[180],"PHASE3","Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants with Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study",[183],"Neovascular Age-Related Macular Degeneration (nAMD)",[185,186,9],"Neovascular Age-Related Macular Degeneration","Tyrosine Kinase Inhibitor","2026-06-29",{"date":189,"type":190},"2026-07-01","ACTUAL",{"date":192,"type":190},"2026-04-27",{"date":194,"type":177},"2030-08-01",{"name":5,"class":6},8]